Objective-The objective of this study was to determine the basis of resistance to atherosclerosis of inbred mouse strain BALB/cJ. Approach and Results-BALB/cJ mice carry a naturally occurring null mutation of the gene encoding the transcription factor Zhx2, and genetic analyses suggested that this may confer resistance to atherosclerosis. On a hyperlipidemic low-density lipoprotein receptor null background, BALB/cJ mice carrying the mutant allele for Zhx2 exhibited up to a 10-fold reduction in lesion size as compared with an isogenic strain carrying the wild-type allele. Several lines of evidence, including bone marrow transplantation studies, indicate that this effect of Zhx2 is mediated, in part, by monocytes/macrophages although nonbone marrow-derived pathways are clearly involved as well. Both in culture and in atherosclerotic lesions, macrophages from Zhx2 null mice exhibited substantially increased apoptosis. Zhx2 null macrophages were also enriched for M2 markers. Effects of Zhx2 on proliferation and other bone marrow-derived cells, such as lymphocytes, were at most modest. Expression microarray analyses identified >1000 differentially expressed transcripts between Zhx2 wild-type and null macrophages. To identify the global targets of Zhx2, we performed ChIPseq (chromatin immunoprecipitation sequencing) studies with the macrophage cell line RAW264.7. The ChIP-seq peaks overlapped significantly with gene expression and together suggested roles for transcriptional repression and apoptosis. Conclusions-A mutation of Zhx2 carried in BALB/cJ mice is responsible in large part for its relative resistance to atherosclerosis. Our results indicate that Zhx2 promotes macrophage survival and proinflammatory functions in atherosclerotic lesions, thereby contributing to lesion growth. Visual Overview-An online visual overview is available for this article.
I
n previous genetic studies in mice, we identified a locus with a modest effect on plasma cholesterol and triglyceride levels on chromosome 15 1 and subsequently used a positional cloning approach involving the analysis of congenic mouse strains to fine map and identify the putative transcription factor Zhx2 as causal. 2, 3 One of the parental strains used in the original genetic cross, BALB/cJ, was found to carry a retroviral insertion that rendered the transcript unstable, essentially resulting in a null mutation with little or no functional protein. The same Zhx2 gene mutation had previously been demonstrated to contribute to reduced silencing of AFP (α-fetoprotein) in adult liver in the BALB/cJ strain. 4 A separate substrain of BALB/c, BALB/cByJ, did not carry the Zhx2 mutation, and in genetic crosses between the substrains, plasma triglycerides and cholesterol levels segregated with the Zhx2 gene. Zhx2 is expressed in a variety of cell types, but we showed using a hepatocyte-specific transgenic expression of Zhx2 that the effect on plasma lipids is mediated entirely by hepatic Zhx2. 2 In addition to its transcriptional role in regulating AFP in hepatocytes, recent studies have shown an involvement of Zhx2 in hepatocellular carcinoma, 5 lymphoma, 6, 7 and myeloma. 8, 9 These findings support both the characterization of Zhx2 as a transcriptional repressor and a tumor suppressor. 10 We now report an analysis of the effects of Zhx2 expression on atherosclerosis in low-density lipoprotein receptor null (Ldlr −/− ) mice. Our results identify Zhx2 as a significant regulator of atherosclerosis, in part, through its effects on bone marrow (BM)-derived cells although the levels of circulating blood cells were not discernibly affected. Zhx2 deficiency resulted in a substantial increase in macrophage apoptosis in lesions and an enrichment of M2 markers. We show that Zhx2 has broad effects on gene expression in macrophages, and we identify some of the direct targets of Zhx2 using ChIP-seq analysis. To determine the mechanistic basis of the effects of Zhx2 on atherosclerosis, we have examined macrophage proliferation, apoptosis, and inflammatory functions.
Materials and Methods
The data that support the findings of this study are available from the corresponding author on reasonable request.
Animals
BALB/cJ mice carrying the endogenous Zhx2 −/− allele (Zhx2 null) were obtained from the Jackson Laboratory and mated with BALB/ cBy Ldlr −/− mice with the Zhx2 +/+ allele (wild type [wt] ). Pups heterozygous for the Zhx2 null mutation and Ldlr −/− were then backcrossed with selection at each generation to strain BALB/cJ for 5 generations and then intercrossed to generate BALB/cJ Ldlr −/− mice carrying the Zhx2 wt, Zhx2
+/−
, and Zhx2 null gentoypes used for experiments. Mice were maintained on a chow diet or a Western diet (Open Source D12079B). For atherosclerosis studies, male and female mice were maintained on a chow diet until 8 weeks of age and then placed on a Western diet for 18 or 24 weeks. Adult mice were euthanized using isoflurane in accordance with Animal Research Committee policies. For in vivo studies, we generally used both male and female mice while for in vitro studies, where sex differences are unlikely to be as important, we generally used 1 sex depending on availability.
Genotyping
DNA was isolated from mouse ear or tail tissue using the Qiagen DNeasy kit. Genotyping was performed using polymerase chain reaction (PCR; TaKaRa reagents) followed by agarose gel separation of amplified products to determine size. DNA genotyping of blood isolated from BM recipients was performed using Sigma Extract-n-amp kit. Zhx2 primers: Zhx2-F 5′ACTGTCTCAGCTCATTCCCTGCAA 3′; Zhx2-R 5′AATGCTTCACATGGCACACAGCAG 3′; Zhx2-MR 5′TCTGCCATTCTTCAGGTCCCTGTT 3′; Ldlr primers: LDLR-F: 5′ACCCCAAGACGTGCTCCCAGGATGA 3′, LDLR-Rwt: 5′CGC AGTGCTCCTCATCTGACTTGT 3′; LDLR-Rko: 5′AGGTGAGAT GACAGGAGATC 3′
Lesion Analyses
After euthanization, the chest cavity of the mouse was opened and the vasculature was perfused with PBS. Quantification of atherosclerotic lesions was determined in the aortic sinus and proximal aorta by sectioning and staining with oil red O, [11] [12] [13] and en face analysis was performed on aortic arch and distal aorta as previously described. 3 This study adhered to the guidelines for experimental atherosclerosis studies as described in the American Heart Association Statement.
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Plasma Lipid Analysis
Male and female mice were fasted for 4 hours beginning at 6 am and bled through the retro-orbital vein into microtainer tubes containing 0.5 mol/L EDTA. After centrifugation, plasma was collected and subjected to quantification of high-density lipoprotein and nonhigh-density lipoprotein cholesterol and other lipids as previously described.
2
Macrophage Collection, Treatment, and RNA Isolation Female mice at 16 weeks of age fed a chow diet were injected in the intraperitoneal cavity with 4% thioglycolate (Brewer Thioglycollate Medium, BD#211716). On the fourth day after injection, macrophages were collected through lavage of the peritoneal cavity using PBS buffer. Collected cells were treated with ACK (ammonium-chloride-potassium) lysis buffer (Fisher Scientific BW10-548E) to remove red blood cells and were then cultured overnight in DMEM media with 20% fetal bovine serum (FBS). The next morning, the cell culture dishes were rinsed with PBS, and RNA from the cell cultures was collected using RNA lysis tissue buffer from the Qiagen RNeasy kit. RNA was isolated with the Qiagen RNeasy kit following the manufacturer's protocol.
Lipopolysaccharide Treatment
After rinse with PBS the morning after cell harvest, media containing 1% FBS was added to cell cultures; lipopolysaccharide (LPS) at a final concentration of 2 ng/mL was used for the subset of samples to be treated. After 4 hours, RNA from the cell cultures was collected and isolated as above.
Gene Expression
cDNA was synthesized with Applied Biosystems High-Capacity cDNA Reverse Transcription Kit. Roche and KAPA Biosystems SYBR green reagents were used for reverse transcription-quantitative PCR (RT-qPCR), and reactions were processed on 384-well plates on the Roche LightCycler 480. RT-qPCR primer sequence for Zhx2-F: 5-′ACACTGATAGGAAGCTGCCTGGT-3′, Zhx2-R: 5′-TCAAATG CCTTTGGCTTCCCTTGG-3′, 36B4-F: 5′-TGAAGCAAAGGAAG AGTCGGAGGA-3′, 36B4-R: 5′-AAGCAGGCTGACTTGGTTGCT TTG-3′. Affymetrix HT Mouse Genome 430 array plates were used for microarray analysis.
BM Transplantation
BM donors were euthanized at ≈6 weeks of age on the day of the transplant, and BM was collected from the tibias and femurs. All mice were male. Briefly, the bones were flushed with DMEM media into a falcon tube using a syringe. Media containing the flushed BM was kept on ice. After all BM was harvested, the collected media was passed through a 70-µm filter (BD falcon 352350), treated with ACK lysis buffer, and rinsed with fresh DMEM. BM cells were counted and kept on ice; a minimum of 10 million cells were given to each BM recipient (females) were between 6 and 8 weeks of age. On the day of the transplant, recipients were given a dose of 8 Gy radiation using a cesium source, and BM cells were transplanted using tail-vein injection. Mice were maintained in sterile cages with antibiotics in the water and autoclaved food for a 4-week recovery period, after which they were placed on a Western diet for 18 weeks. 
Colony-Forming Assay
T-Cell Experiments
Secondary lymphoid organs (spleen, popliteal, and inguinal lymph nodes) were crushed and treated with 1 mg/mL collagenase type 3 (Worthington Biochemical) for 1 hour. CD11c + dendritic cells, regulatory T-cells, and CD4
+ T-cells were isolated using antibodies coated with magnetic beads (Miltenyi Biotec). All dendritic cells were treated with 50 μg/mL mitomycin C (Sigma-Aldrich M4287) and washed. For all T-cell isolations, Zhx2 wt and null isogenic, Ldlr −/− mice on a BALB/cJ background were used. For dendritic cell and regulatory T-cell isolation, BALB/cByJ were also used. All mice were fed a regular chow diet. Cells were cultured for 72 hours and pulsed with 1 μCi 3 H-thymidine (Perkin Elmer) for the last 18 hours. After the 72-hour incubation, 3 H-thymidine incorporation was used to determine T-cell proliferation and activation by scintillation counting. All of the studies resulted in insignificant differences between Zhx2 wt and null mice (Tables I-V in the online-only Data Supplement). 
Effect of
Detection of Ki-67 in Atherosclerotic Lesions
Immunofluorescence was performed on tissue sections from frozen, optimal cutting temperature compound-embedded proximal aortas from wt and null male mice. Antibodies to CD68 (MCA1957GA, Biorad) and Ki-67 (ab15580, abcam) were used to detect macrophages and cell proliferation, respectively. Antibody to CD68 or Ki-67 was detected with AlexaFlour 594-conjugated antibody to rat IgG (Life Technologies) or AlexaFlour 488 conjugated antibody to rabbit IgG (Life technologies). The nuclei were stained with DAPI (4',6-diamidino-2-phenylindole; Sigma-Aldrich). The quantification of Ki67 staining was done by normalizing the Ki67-positive nuclei colocalized with CD68 to total nuclei numbers in CD68 stained area. We used a Zeiss LSM 880 confocal microscope to visualize the staining.
In Vivo 5-Ethynyl-2′-Deoxyuridine (EdU) Incorporation and Detection
Male Ldlr −/− mice were maintained on an atherosclerotic diet for 24 weeks. A total of 1.26 mg EdU (from 10 mmol/L stock solution) was injected intraperitoneally. Mice were euthanized 2 hours later, and 10 µm cryo-sections from frozen, optimal cutting temperature compound-embedded proximal aortas were prepared. EdU was detected in these tissue sections using the Click-iT EdU Alexa Fluor 488 Imaging Kit (Invitrogen) using vendor's protocol. CD68 (MCA1957GA, Biorad) was used to identify macrophages. The number of EdU-positive nuclei was normalized to the total number of CD68-positive macrophages in lesions. The images were taken using a Zeiss LSM 880 confocal microscope.
In Vivo TUNEL Assay
Male mice were fed an atherosclerotic diet for 24 weeks. After sacrificing, the mice 10 µm cryo-sections were prepared as described above. Apoptotic cells in the atherosclerotic lesions were detected using the Click-it Plus TUNEL (terminal deoxynucleotidyl transferase dUTP nick-end labeling) Assay kit (C10617, Thermo Fischer Scientific) following the manufacturer's protocol with slight modifications. In particular, the permeabilization time was increased from 15 to 20 minutes. CD68 (MCA1957GA, Biorad) antibody was used to identify the macrophages. The number of TUNEL-positive nuclei was normalized to the total number of CD68-positive macrophages in the lesions. The images were taken using a Zeiss LSM 880 confocal microscope.
Isolation of BMDM
BM cells were isolated from femurs of male wt or null mice. Cells were treated with red blood cell lysis buffer to remove red blood cells for 5 minutes, centrifuged at 364g for 5 minutes, and resuspended in BMDM culture medium. Culture medium consisted of high-glucose DMEM (Gibco 11965) supplemented with 10% heat inactivated FBS, 2 mmol/L L-glutamine, 100 U/mL, 100 µg/mL penicillin/streptomycin, 500 μmol/L sodium pyruvate, and 5% v/v conditioned medium containing M-CSF to induce differentiation to BMDMs. BMDMs were maintained at 37°C in a humidified 5% CO 2 incubator. BMDMs were differentiated for 6 days before experiments, and medium was changed at day 4 of differentiation. For qPCR analyses, RNA was isolated with TRIzol and cDNA synthesized with high-capacity cDNA RT kit. KAPA SYBR FAST qPCR master mix (2) kit and a lightCycler 480 were used for quantitative RT-PCR. Fold change related to the control was calculated using 36b as the reference gene.
TLR Ligand Treatment of Zhx2 wt and Null BMDM
For determination of proliferation, 1.45 μmol/L of calcein-AM (final concentration) was added to each well and incubated for 15 minutes. Plates were then imaged using ImagesXpress XL (Molecular Devices). The 2O high magnification fluorescence images were captured for each well (21.83% of total well surface area) using a ×10 objective. Cell number was calculated using MetaXpress Software using the multiwavelength cell scoring module.
Immunocytochemistry of Cultured Cells Using Ki67, EdU, and TUNEL
For Ki-67 experiments: BMDM from male wt and ZhX2 null mice were cultured in 8 wells culture slides. Cells were seeded at 20 000 cells per well with 10 ng/mL recombinant M-CSF. On day 6, the cells were starved for serum and M-CSF for 18 hours and then treated with different concentrations of mouse recombinant M-CSF (STEMCELL Technologies, Vancouver, Canada) for 48 hours. Cells were washed with PBS and fixed with 4% paraformaldehyde (10 minutes), permeabilized with 0.1% Triton X-100 (10 minutes), and were blocked with 3% BSA and 5% goat serum (in 1× PBS) for 1 hour at room temperature. Cells were incubated with Ki-67 (ab15580, abcam) and CD68 (MCA1957GA, Biorad) for overnight at 4°. Cells were washed and further incubated with goat anti-rat, Alexa Fluor 594 (A-11007, ThermoFischerScientific) and goat anti-rabbit, Alexa Fluor 488 (A-11008, ThermoFischerScientific) for 1 hour at room temperature. Slides were washed and mounted with DAPI (Sigma Aldrich).
For EdU staining, BMDM from male Zhx2 wt and null mice were cultured in 8 well culture slides at 20 000 cells per well with 10 ng/ mL of mouse recombinant M-CSF (STEMCELL Technologies). On day 6, cells were starved for serum and M-CSF for 18 hours and then treated with different concentrations of M-CSF (0, 4, 20, 100, and 500 ng/mL) for 48 hours. Click-iT EdU Alexa Fluor 488 Imaging Kit (C10337, Invitrogen) was used to stain incorporated EdU following the manufacturer protocol. All images were taken using a Zeiss (Axioskop 2 plus, Carl Zeiss, Heidelberg, Germany) microscope.
For TUNEL assays, peritoneal (from female mice) and BMDM (from male mice) macrophages from Zhx2 null and Zhx2 wt mice were cultured as above. The apoptosis was determined by TUNEL assay using the Promega DeadEnd Fluorometric TUNEL System G3250 and Click-it Plus TUNEL Assay kit (C10617, Thermo Fischer Scientific), respectively. The manufacturer's protocol was followed for each kit. For some experiments, the BMDM macrophages were treated with oxidized LDL (25 µg/mL) or 7-ketocholesterol (40 µg/ mL) for 24 hours. The images were taken using Nikon (Eclipse Ti-s) and Zeiss (Axioskop 2 plus, Carl Zeiss) microscopes.
Flow Cytometry
Anesthetized male mice were perfused by cardiac puncture with Dulbecco's PBS containing 2 mmol/L of EDTA. Harvested aortas were digested with 250 U/mL collagenase type XI, 120 U/mL hyaluronidase type I-s, 120 U/mL DNAse1, and 450 U/mL collagenase type I (all enzymes, Sigma) in HBSS at 37°C for 1 hour on bacterial shaker. A cell suspension was obtained by mashing the aorta through a 70-µm strainer. Cells were then stained for flow cytometry. Fcγ receptors were blocked using CD16/32 antibody for 15 minutes at room temperature. Surface antigens on cells were stained for 30 minutes at 4°C using appropriate antibodies. Zombie Yellow Fixable Viability Kit (Biolegend) was used for analysis of viability, and forward-and sidescatter parameters were used for exclusion of doublets. Macrophages were identified as live, CD45+, lineage negative (CD19−, CD3 −, CD11c−), F4/80+, CD11b+, cells using a BD LSR II flowcytometer. The cell surface markers, CD86 and CD206, were used to identify M1 and M2 phenotypes, respectively. All antibodies were from Biolegend, San Diego, CA. Data were analyzed using FlowJo software.
Zhx2 ChIP-Seq
Raw 264.7 macrophage cells purchased from American Type Culture Collection were cultured in standard DMEM containing 10%FBS and penicillin/streptomycin at 37° in 5% CO 2 . Cells were transfected using Lipofectamine 2000 according to the manufacturer's protocol. For ChIP-seq experiments, mouse Zhx2 was cloned into a pShuttle-IRES-GFP1 plasmid (ad-gene) where the C-terminal end of the gene contained a 3X-FLAG sequence.
Transfected raw macrophages were washed 2× in cold PBS, fixed using 4% paraformaldehyde, neutralized with acid glycine, and then pelleted at 2 million cells/pellet. These pellets were then fractionated for nuclear isolation using an NPER kit (Thermo cat no. 78833). Nuclear lysate was then sonicated to ≈150 to 300 DNA basepair fragment size for 50 minutes using a Bioruptor ultrasonicator (diagenode). Sonicated lysate was then subjected to ChIP using a kit (Sigma cat no. CHP-1) according to manufacturer details. Briefly, sonicated pellets were immuoprecipitated using 3 μg/2million cells monoclonal FLAG antibody (Sigma cat no. F3165) overnight at 4°. The following day, samples were washed and cross-links reversed via incubation overnight at 65° in 160 mmol/L NaCl. Protein and RNA were then digested (Proteinase K and RNAse digestion 1 hour at 37°) and isolated DNA eluted using a column provided in ChIP-kit.
Isolated DNA from chromatin immunoprecipitation was subjected to library preparation using a Kappa Hyper Prep Kit (Kappa Bio cat no. KK8502) according to the manufacturer's protocol. Briefly, DNA was ligated to adapters (Tru-Seq) and size-selected using AmPURE beads (Agencort cat no. A63880) and washed in 80% ethanol and eluted. Libraries did not require subsequent amplification and were directly sequenced. Input for sequencing was standardized and pooled at 2 μL per 10 nmol/L sample measured using a Qubit fluorometric system (Thermo). The pooled sample was then sequenced in a single lane using a HiSeq4000. This pooled single lane, containing 2 replicates of ZHX2-FLAG and 1% input, produced 100 million total reads.
Sequencing data were downloaded, demultiplexed, and converted to FASTQ files. These files were then aligned to the mouse mm 10 genome using bowtie2. 16 The resulting SAM files were then analyzed using HOMER software. 17 Chip-Seq Plots were produced using ngsplot software and preprocessed using R Studio.
Statistical Analyses
All statistical analyses were executed in the R programming environment. Two-way ANOVA or the Kruskal-Wallis test with Bonferroni correction for multiple comparisons was used to compare multiple groups. The Mann-Whitney test was used to compare 2 groups. Microarray results were normalized using Robust Multiarray Average in the Affymetrix package, and differential expression P values and Venn diagrams were calculated using the limma package. Microarray P values were corrected using Benjamini Hochberg. P<0.05 was considered significant.
For analysis of lesions, a 2-way ANOVA was conducted to identify significant sex and genotype factors and their interactions. Before analysis, lesion size was adjusted to meet the normality and homoscedasticity assumptions. A log transformation was applied to lesion size, and an outlier in the female null category was removed. For each sex by genotype category, the hypothesis of normality was not rejected using the Shapiro-Wilk statistic, and homoscedasticity was not rejected using the Levene test. Removing the single outlier (based on a χ 2 test) provides a more conservative test of the hypothesis. Including the outlier in the female null category did not change the results: sex (P=0.00496), genotype (P=4.41e-11), interaction (P=0.0100).
Results
Absence of Zhx2 Expression in Mice Protects Against Atherosclerosis
When fed a Western diet, atherosclerotic lesions were markedly reduced in BALB/cJ Ldlr −/− mice carrying the Zhx2 null mutation as compared with isogenic mice carrying the type wt allele (from strain BALB/cBYJ) as judged by analysis of sections from aortic root ( Figure 1A) or by en face analysis of the aortic arch ( Figure 1B ). There was a decided sex difference, with male mice typically exhibiting about a 10-fold difference in lesion size whereas females exhibited about a 3-to 4-fold difference. Statistical analysis was performed using 2-way ANOVA to identify significant sex and genotype factors and their interactions. After adjustment to the data to meet normality and homoscedasticity assumptions (see Methods), significant differences were observed for sex (P=0.0061) and genotype (P=2.3e-12). There was also a significant interaction for lesion size between gender and sex. The Zhx2 null phenotype was largely recessive as heterozygous Zhx2 +/− mice had lesion characteristics similar to Zhx2 wt male mice ( Figure 1C) .
We previously observed that, as compared with Zhx2 wt mice, Zhx2 null mice have modestly reduced levels of plasma triglycerides and cholesterol. 2 We showed that this was largely normalized when Zhx2 was expressed specifically in liver using a transgene driven by the transthyretin promoter (TTR-Tg). 2 On an Ldlr −/− background, we also observed significantly reduced levels of plasma triglycerides and cholesterol in male mice ( Figure IA in the online-only Data Supplement) while the levels were not significantly different in females except for a small decrease in triglycerides ( Figure IB in the online-only Data Supplement). Because these differences could contribute to the differences in atherosclerosis, we examined the effect of the TTR-Tg on plasma lipids and atherosclerosis in male Ldlr −/− mice. Although hepatic expression of Zhx2 increased levels of triglycerides and cholesterol in male Zhx2 wt mice ( Figure IC and ID in the online-only Data Supplement), it did not significantly affect atherosclerosis ( Figure ID) . Thus, it seems that the major effect of the Zhx2 deficiency on atherosclerosis is mediated by factors independent of blood lipids.
Effect of Zhx2 on Atherosclerosis Is Mediated in Part by BM-Derived Cells
The lesions of Zhx2 null mice contained reduced macrophages as compared with Zhx2 wt mice ( Figure 2A) . As judged by flow cytometry, the percent macrophage (F4/80+CD11b positive) population (of the CD45+ and Lin− population) appeared to be slightly higher in wt compared with Zhx2 null mice (P=0.06; Figure II in the online-only Data Supplement). We hypothesized that Zhx2 might influence atherosclerosis by effects on BM-derived cells. To determine the contribution of hematopoietic stem cells arising from BM to atherosclerosis, we performed a BM transplantation study with Zhx2 wt mice. BM was irradiated and then replaced with donor Zhx2 wt or Zhx2 null BM. Measurement of atherosclerotic lesion size showed more than a 3-fold decrease in atherosclerosis in the wt mice transplanted with Zhx2 null BM as compared with mice transplanted with wt BM ( Figure 2B) . In experiments to determine the effect of nonhematopoietic stem cell tissues on atherosclerosis, we transplanted Zhx2 null BM into either Zhx2 wt or Zhx2 null recipients. These studies demonstrated that an ≈4-fold effect on atherosclerotic lesions size persists after normalization for BM genotype ( Figure 2C ), indicating that Zhx2 works through >1 cell system to affect atherosclerosis.
All mice in these studies were monitored by genotyping blood cells for the Zhx2 alleles using PCR ( Figure III in the online-only Data Supplement). Although Zhx2 wt mice transplanted with Zhx2 null BM showed no evidence of retention in blood of the Zhx2 wt allele, irradiated Zhx2 null transplanted with Zhx2 wt BM consistently showed a low level of the Zhx2 Because all mice were irradiated at similar levels, in some cases in the same cages, it seems that Zhx2 may also affect sensitivity to irradiation.
The number of monocytes and other leukocytes in the circulation did not differ significantly between Zhx2 wt and Zhx2 null cells on either the chow or Western diet. On the Western diet, Zhx2 null mice appeared to have more lymphocytes ( Figure 2D ). To identify possible differences in the differentiation of monocytes/macrophages from hematopoietic stem cells, we performed a colony-forming cell assay on BM cells from both Zhx2 wt and Zhx2 null and found no differences between the 2 strains ( Figure 2E ).
Because T cells play a significant role in atherosclerosis, including mouse models, 18, 19 we performed several assays to examine effects of Zhx2 deficiency on CD4+ T-cell priming and restimulation, proliferation, and suppression. All such studies were negative because there were no significant differences between cells from Zhx2 null as compared with Zhx2 wt mice (Tables I-V in the online-only Data Supplement).
Modest Effects of Zhx2 on Macrophage Proliferation
To test for potential effects of Zhx2 on macrophage proliferation, we used either immunostaining for Ki67, a marker of cell division, or incorporation of Edu. For the analysis of lesions, macrophages were identified using the markers CD68 or Mac3. In some experiments, Ki67 immunostaining suggested increased proliferation of Zhx2 wt as compared with null macrophages although the small size of lesions in Zhx2 null mice made quantification difficult ( Figure IVA and IVB in the online-only Data Supplement). More consistent results were obtained using EdU incorporation, which showed a trend toward increased proliferation in wt mice ( Figure IVC and IVD in the online-only Data Supplement).
In order for more accurately assess Zhx2 effects on proliferation, we examined cultured BMDM and again assessed proliferation using Ki67 or EdU incorporation. We preformed the experiments at varying concentrations of M-CSF, a key driver of macrophage proliferation. At low M-CSF concentrations, no differences were observed but at higher concentrations Zhx2 wt macrophages showed a slight increase in proliferation ( Figure IVE -IVH in the online-only Data Supplement). The effective concentration of M-CSF in lesions is unknown. As discussed below, Zhx2 genotype did not affect the proliferation of BMDM in response to a variety of TLR ligands.
Zhx2 Null Mice Exhibit Increased Apoptosis in Lesions and In Vitro
The effects of Zhx2 in apoptosis were examined using TUNEL assay. Lesional macrophages were identified using the marker CD68. Figure 3A shows representative sections of Zhx2 wt and null lesions immunostained with antibodies to CD68 and TUNEL. The fraction of double positive cells indicated that the level of apoptosis in Zhx2 null was dramatically increase as compared with wt ( Figure 3B ).
To confirm these findings and further examine the underlying mechanism, we quantitated apoptosis in cultured BMDM and peritoneal macrophages. Using TUNEL staining, BMDM from Zhx2 null mice showed an ≈2-fold increase in apoptosis ( Figure 3C and 3D) . In Ldlr −/− mice maintained on a Western diet, peritoneal macrophages from Zhx2 null mice showed an ≈3-fold increase of apoptosis as compared with macrophages from Zhx2 wt mice ( Figure 3E and 3F) . In contrast, peritoneal macrophages from mice maintained on a chow diet exhibited little or no difference in apoptosis ( Figure 3E and 3F) . Thus, there seems to be an interaction between the expression of Zhx2 and cholesterol loading with respect to macrophage apoptosis. We also performed the TUNEL assay on BMDM treated with oxidized LDL or 7-ketocholesterol. The effect of Zhx2 genotype was similar in each of the experiments ( Figure 3C) 
Zhx2 Regulation and Effects on Gene Expression in Macrophages
Macrophages from Zhx2 wt and Zhx2 null mice on a BALB/ cJ, Ldlr −/− background were isolated, cultured, and a subset treated with bacterial LPS. Macrophages isolated from Zhx2 wt mice showed an increase of ≈8-fold in Zhx2 transcript levels after LPS treatment in male mice ( Figure 3G ). Similar studies in macrophages from a panel of inbred mouse strains on a chow diet 20 showed only modest variation in Zhx2 basal levels (with the exception of BALB/cJ) but wide variation in response to LPS treatment (Table VI in the online-only Data Supplement), ranging from no induction in the TLR4 −/− strains such as C3H/HeJ to 24-fold in strain AxB-10 (Table VI in the online-only Data Supplement).
To examine the effect of Zhx2 deficiency on gene expression, thioglycollate-induced peritoneal macrophages were isolated from male and female chow-fed Zhx2 wt and Zhx2 null mice. The expression profiles were determined by microarray analysis, and differentially expressed transcripts were identified by comparing the wt to null expression data. Nearly 1400 probes were differentially expressed between macrophages isolated from chow-fed Zhx2 wt and Zhx2 null mice, in both males and females (Table VII in the online-only Data Supplement). Of the genes differentially expressed among both sexes, ≈600 were regulated >2-fold, with some genes being differentially expressed >100-fold. The top differentially expressed genes were all repressed in the presence of Zhx2. Gene ontology analysis performed on these genes identified the immune response category as the most enriched in the data set, with a corrected P value of 2.0×10 -25 (Table VIII in the online-only Data Supplement). Other notable significantly enriched Gene Ontology categories include antigen presentation and apoptosis.
Given that the status of macrophage polarization has been demonstrated as an important contributing factor to atherosclerosis, 21 we also asked if there was significant enrichment of M1 or M2 macrophage markers between Zhx2 wt and Zhx2 null mice. Of the 743 genes significantly enriched in the wt mice, 37% of the genes have been annotated as M1 macrophage markers, 22 whereas <5% of marker genes were enriched in the null group (Table VIII in the online-only Data Supplement). Conversely, 42% of the genes upregulated in Zhx2 null macrophages have been annotated as M2 macrophage markers (Table VIII in the online-only Data Supplement). These data suggest a role of Zhx2 in promoting gene expression signatures, consistent with M1 macrophage polarization.
To further examine this, we performed flow cytometric analysis on lesional macrophages from mice fed an atherogenic diet using specific markers for M1 (CD86) and M2 (CD206). A significantly higher percentage of CD86-positive cells was observed in Zhx2 wt compared with null mice consistent with the conclusion that Zhx2 promotes an M1 phenotype ( Figure 3H ).
We also examined the effect of Zhx2 genotype on responses to a variety of TLR ligands, including TLR1/2, TLR3, TLR4, TLR7/8, TLR9, and the M1 inducer LPS+interferon γ. BMDM were plated at various densities and proliferation after the treatments was assessed as previously described 23 ( Figure V in the online-only Data Supplement). In general, TLR stimulation inhibited the growth of Zhx2 wt and null cells to the same extent, similar to treatment of BMDM from C57BL/6J mice. We also examined the expression of several proinflammatory cytokines and chemokines (IL1b, IL12b, TNFa, and CXCL10) after treatment with TLR ligands. Effects were negligible or modest ( Figure V in the online-only Data Supplement).
Chip-Seq Analysis
Efforts to carry out global analysis of Zhx2 binding to chromatin using antibodies have previously been unsuccessful. Therefore, we tagged Zhx2 with a 3X-FLAG at the carboxyl terminus and showed that it remained active, as judged by changes in gene expression, when transfected into the RAW mouse macrophage cell line (see Methods). To perform ChIP-seq, the FLAG-tagged Zhx2 was overexpressed in RAW macrophages and then subjected to cross-linking, immunoprecipitation, and subsequent sequencing of bound DNA. We detected significant enrichment of 5402 peaks (5% false discovery rate and >2-fold enrichment over input). The locations of the peaks with respect to genes are summarized in Table IX in the online-only Data Supplement. To further refine our analysis, we chose to focus on regions which were <1 MB from a coding gene and achieved a highly stringent level of significance (1% FDR and >4-fold enrichment over input). We narrowed this list to 384 total peaks which met this criterion. Pathway enrichment of this list of genes alone was not highly-informative as to the function of the protein. To gain a more comprehensive snapshot of Zhx2 function, we overlapped macrophage genes that showed stringent Zxh2 ChIP-seq enrichment and induction of expression in the Zhx2 null versus wt macrophage gene expression. Roughly half of the 384 genes from the ChIP-Seq analysis also showed significant induction in the null versus ) between ChIP-Seq and expression arrays (Table X in the online-only Data Supplement). We observed significant enrichment for transcriptional repression, as well as apoptosis, suggesting Zhx2 binds DNA to repress expression of apoptosis genes in macrophages (Table XI in the online-only Data Supplement). Two known regulators of apoptosis, Jun 24, 25 and Bcl6, 26, 27 which showed overlap in this analysis are shown in Figure 4A . It is noteworthy that Bcl6 is known to repress inflammation and atherosclerosis. 28 We also performed motif enrichment on the Chip-seq data. The top-ranked candidate based on motif enrichment was the transcriptional repressor Yin-Yang-1 ( Figure 4B ). Although Yin Yang 1 has been implicated in many biological processes, several studies have observed a robust capacity of the transcriptional repressor to suppress expression of apoptotic genes, 29, 30 offering further evidence of overlapping roles of Zhx2 and Yin Yang 1.
Discussion
Our studies reveal a dramatic effect of Zhx2 expression on atherosclerosis development in the Ldlr −/− mouse model. Strain BALB/cJ mice have long been known to be particularly resistant to atherosclerosis, 31 and our study now shows that this is largely because of the mutation in Zhx2 (Figure 1) . We previously showed that hepatocyte-specific expression of Zhx2 using a transgene driven by a transthyretin promoter normalized plasma lipids, and we observed that the transgene does not significantly affect atherosclerosis. Thus, the susceptibility to atherosclerosis seems to be largely independent of the effects of Zhx2 on plasma lipids, AFP, or expression in liver. Because Zhx2 is expressed in most cell types, including BM-derived cells and vascular cells, the cell types critical for lesion development were unclear. In the absence of cell-specific Zhx2 null mice, we decided to carry out BM transplantation experiments, and these revealed that the atherosclerosis phenotype is partially mediated by BM-derived cells, presumably macrophages or lymphocytes (Figure 2 ). Leukocyte levels were not affected by the Zhx2 mutation nor did we observe any significant differences in monocyte or lymphocyte characteristics. We performed a series of studies to examine lymphocyte immune functions but failed to identify any effects of Zhx2 deficiency (Tables I-V in effect of Zhx2 expression on atherosclerosis was related to macrophage functions, we quantitated both macrophage proliferation and apoptosis in lesions. The Zhx2 null mice exhibited only modestly reduced proliferation ( Figure IIIA -IIIH in the online-only Data Supplement) but significantly increased apoptosis, both in vitro and in lesions, as judged by TUNEL staining (Figure 3A-3F) . To examine the mechanisms by which Zhx2 affects macrophage functions, we performed analysis of the effects of Zhx2 on global transcript levels and also performed ChIP-seq analyses to identify the direct targets of Zhx2. We also examined the expression of M1/M2 markers and the responses to inflammatory ligands. The results support a role of Zhx2 in macrophage apoptosis and suggest that Zhx2 expression promotes inflammatory functions (Figure 4) .
We originally identified the Zhx2 locus on mouse chromosome 15 using quantitative trait locus mapping of a cross between inbred strains BALB/cJ and MRL/lpr 1 and, subsequently, isolated the locus as a congenic region on a BALB/ cJ background. 3 We then performed crosses to narrow the locus to about a dozen genes and then examined these oneby-one, revealing that Zhx2 for strain BALB/cJ exhibited dramatically reduced expression because of a retroviral insertion.
2 During the course of these studies, we performed a preliminary investigation of the potential impact of the Zhx2 null allele on atherosclerosis using a cholic acid-containing diet 31 and observed a decrease as compared with the wt allele. To explore this further, we have now introduced the wt allele from the closely related strain BALB/cByJ onto a BALB/cJ background and have introduced an Ldlr −/− -targeted gene mutation onto both the Zhx2 null and Zhx2 wt BALB/cJ backgrounds. On this background, we observed a dramatic impact of Zhx2 on lesion development, with Zhx2 null mice protected by ≈10-fold in males and 3-to 4-fold in females (Figure 1 ).
Zhx2 seems to be a transcriptional repressor, originally shown to be involved in the modulation of AFP expression in newborn mice. 4 Using microarrays, we examined the effects of Zhx2 deficiency in peritoneal macrophages. Expression levels of hundreds of genes were significantly affected, and the differentially expressed gene set was significantly enriched for immune response genes, including apoptosis. Consistent with this, we observed a striking induction of Zhx2 in response to the proinflammatory stimulus LPS, which induces an inflammatory response in macrophages through the activation of the TLR4 receptor. Recent studies describe downstream TLR4 activation of XBP1, a potent transcriptional activator. 32 Separate studies on a Hodgkin lymphoma cell line identified a chromosomal rearrangement that represses Zhx2 expression, 7 and a further study suggested that these mutations prevented the binding of XBP1 to the Zhx2 regulatory region. 6 These findings are consistent with a hypothesis of LPS regulation of Zhx2 through the Tlr4-Xbp1 pathways. In addition to our data on the role of Zhx2 in macrophages, recent studies have described a role for Zhx2 in other leukocytes 6, 8, 9 and in adaptive immunity, 33 indicating multiple roles for Zhx2 in BM-derived cells of the immune system. The available antibodies to Zhx2 exhibited significant nonspecific binding, and thus we were unable to determine whether Zhx2 was upregulated in lesions.
We were successful in a global analysis of Zhx2 targets using ChIP-seq analysis. We used a macrophage cell line given the evidence that the effect of Zhx2 deficiency on atherosclerosis is mediated, in part, by BMDM. It is likely that the chromatin interactions of Zhx2 would differ in other cell types; for example, Zhx2 is clearly involved in the repression of AFP and, yet, we observed no significant enrichment of sequences near the gene in macrophages. It is possible, of course, that the repression of AFP represents a secondary effect. The ChIP-seq results showed significant overlap with the expression data obtained by comparing Zhx2 wt with Zhx2 null macrophages. Both data sets are consistent with a role in apoptosis of macrophages. In addition, expression array data suggested a role for Zhx2 in regulation of macrophage polarization, specifically promoting an M1 proinflammatory transcriptional signature. A role in inflammatory functions is also suggested by the finding that Zhx2 is induced by LPS treatment ( Figure 3H) .
A proapoptotic role of Zhx2 would be consistent with its role as a tumor suppressor in lymphomas and myelomas, where a deficiency of Zhx2 has been associated with cancer. 6, 8 This contrasts to the situation in macrophages, where Zhx2 deficiency promotes apoptosis and reduces the development of atherosclerotic lesions. Although we observe strong evidence for a role of Zhx2 in macrophage survival, our BM studies indicate that effects in non-BM-derived cells explain a significant fraction of the effect on atherosclerosis. Zhx2 is expressed in both endothelial cells and smooth muscle cells. 34 As it has also been described as a developmental repressor in the liver 4 and brain, 35 it is possible that activity of the gene can affect disease pathology in a variety of tissues.
Our results may also be relevant to the recent findings that clonal hematopoiesis can increase risk of atherosclerosis since a likely mechanism involves increased macrophage proliferation or apoptosis in lesions. 36, 37 It is also clear that non-BM-derived cells contribute to the effects of Zhx2 on atherosclerosis, and we have not definitively ruled out the possibility that BM-derived cells other than macrophages contribute. Our results are also of potential relevance to the finding that a locus containing the Zhx2 gene was significantly associated with coronary intima media thickness, a subclinical measure of atherosclerosis, in a genome-wide association study. However, no evidence of significant association of the locus was observed in large association studies for other cardiovascular disease traits. [38] [39] [40] Several important questions remain to be answered. The mechanisms by which Zhx2 affects macrophage apoptosis and inflammation are unclear. As a transcription factor with broad effects, it is likely to influence a variety of relevant pathways. Also, the effects of Zhx2 on atherosclerosis are clearly mediated, in part, by non-BM-derived cells, and the identity of these cells is unknown. This issue can probably be best pursued using tissue-specific modulation of Zhx2 expression. Finally, we have performed only the initial characterization of the genomic targets of Zhx2 and its interactions with other transitional regulators. For example, it is known to form heterodimers with other members of the zinc finger and homeoboxes family.
